🇮🇳IN
Sign In
AA

AARTIPHARM

NSE

Aarti Pharmalabs Ltd

₹820.85

-7.95(-0.96%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

AARTIPHARM valuation summary

Aarti Pharmalabs Ltd trades at 42.1 times trailing earnings. Return on equity is 9.3% and return on capital employed is 11.4%. The dividend yield is 0.36%.

P/E42.1
ROE9.3%
ROCE11.4%
Dividend yield0.36%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer